Search results
FDA official: The risk of secondary cancer from CAR-T therapy is less than feared
Medical Xpress· 10 hours agoThe risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared...
Kyverna's CAR-T relapse in lupus dents autoimmune hopes amid biotech gold rush
FierceBiotech· 11 hours agoThe “remarkable” success of chimeric antigen receptor T-cell therapy (
CARsgen’s CAR T MM therapy shows early signs of efficacy in Phase I trial
Clinical Trials Arena via Yahoo Finance· 10 hours agoT cell therapy accounts for 55% of all adoptive cell therapy trials, according to data obtained ...
New Clues to Origin of T-Cell Lymphoma After CAR-T Therapy
MedPage Today· 6 days agoOnly one of 724 patients treated with chimeric antigen receptor (CAR) T-cell ...
Boosting CAR-T cell therapies from under the skin
Medical Xpress· 5 days agoCAR-T cells are created from a patient's own immune T cells by introducing so-called "chimeric antigen< ...
APAC leaps ahead in adoptive cell therapy space
Clinical Trials Arena via Yahoo Finance· 7 hours agoAdoptive cell therapies are immunotherapies that use engineered...natural killer (NK) cell immunotherapy, and T cell
Risk of secondary cancers after CAR-T cell therapy low, according to large study
Medical Xpress· 5 days agoA large study by researchers at Stanford Medicine has found that the risk of secondary blood cancers...
Immunotherapy to treat cancer gave rise to 2nd cancer in extremely rare case
LiveScience· 4 days agoIn an extremely rare case, a patient who received a cell-based cancer treatment later developed a...
CAR-T Treatment Continues to Astonish in Rheumatologic Diseases
MedPage Today· 6 days agoNew data reported here reinforce the idea that chimeric antigen receptor T-cell (CAR< ...
Researchers find significant racial disparities in who has access to CAR-T therapy
Medical Xpress· 6 days agoPenn Medicine's patients of color are far less likely than white patients to receive a novel gene ...